NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Cephalon Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Accuray Announces Additions to Board of Directors
2009 SEP 28 ... Chiron Corporation. Winger also serves on the boards of directors of Cell Genesys, Inc., Cephalon, Inc. and Vertex Pharmaceuticals. "We are pleased to have two of the ...
Subject: Accuray Incorporated
Price: $3.00
*
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
2009 OCT 5 ... Drugs, FDA, Regulatory Actions, Therapy, Treatment, U.S. Food and Drug Administration, Cephalon Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Drug Development
Price: $3.00
*
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
2009 NOV 9 ... Cephalon, Drugs, Enbrel, Etanercept, Pharmaceuticals, Therapies, Therapy, Treatment, Cephalon Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Pharmaceuticals
Price: $3.00
*
Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
2009 NOV 9 ... Central Nervous System Infection, Cephalon, Drugs, Oncology, Therapy, Treatment, Cephalon Inc. This article was prepared by Pain & Central Nervous System Week editors ...
Subject: Central Nervous System Disease
Price: $3.00
*
Cephalon Notified of Generic Filing for Armodafinil Tablets
2009 NOV 2 ... Pharmaceutical Industries Ltd., Therapy, Treatment, U.S. Food and Drug Administration, Cephalon Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Biotechnology Business
Price: $3.00
*
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
2009 NOV 9 ... Necrosis, Pharmaceuticals, Sciatica, Spinal Disorders, Therapies, Therapy, Treatment, Cephalon Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Sciatica
Price: $3.00
*
Cephalon, Inc. to Webcast R&D Day
2009 NOV 16 ... Company, Cephalon, Congenital Lobar Emphysema, Lupus, Pulmonology, Therapy, Treatment, Cephalon Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Biotechnology Business
Price: $3.00
*
Critical Alerts for Microsoft, US Steel, Cephalon, Eaton, and Harmony Gold Released by Seven Summits Research
2009 NOV 16 ... stocks: Microsoft Corporation (NASDAQ:MSFT), United States Steel Corp. (NYSE:X), Cephalon Inc. (NASDAQ:CEPH), Eaton Corporation (NYSE:ETN), and Harmony Gold Mining Co. Ltd. ...
Subject: Seven Summits Investment Research
Price: $3.00
*
CytRx and Cephalon Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia
2009 SEP 28 ... tamibarotene combined with TRISENOX® (arsenic trioxide) injection (marketed by Cephalon, Inc.) in patients with relapsed acute promyelocytic leukemia (APL). There are two ...
Subject: CytRx Corporation
Price: $3.00
*
Heartbeat Digital to Speak at FDA Hearing
2009 NOV 23 ... The agency's healthcare clients include Amgen, Auxilium, Bayer, Becton Dickinson, Cephalon, Endo Pharmaceuticals, Life Line Screening, Mayo Clinic, Memorial Sloan-Kettering Cancer ...
Subject: Heartbeat Digital
Price: $3.00
*
Ligand Updates License Agreement with Exelixis
2009 NOV 16 ... pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, Pfizer and Wyeth Pharmaceuticals. With nine ... Incorporated (NASDAQ: LGND) has amended its license agreement with Exelixis, Inc. (NASDAQ: EXEL) as a result of which Ligand is now entitled to receive royalties on net ...
Subject: Ligand Pharmaceuticals Incorporated
Price: $3.00
*
Ligand's JAK3 Research Collaboration Extended by Pfizer
2009 NOV 16 ... pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, Pfizer and Wyeth Pharmaceuticals (now Pfizer). With ... Hematopoietic, Hormones, Immunology, Inflammation, Kinase, Ligand Pharmaceuticals Inc., Marketing and Licensing Agreements, Osteoporosis, Pfizer, Pharmaceutical Business, ...
Subject: Ligand Pharmaceuticals Incorporated
Price: $3.00
*
Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work Disorder
2009 NOV 16 ... Cephalon, Inc. (NASDAQ: CEPH) announced that the November issue of Mayo Clinic Proceedings has ...
Subject: Cephalon, Inc.
Price: $3.00
*
New cancer study results from National Cancer Institute described
2009 NOV 16 ... characteristic features required for tumorigenesis. Small molecule inhibitors, such as Cephalon's CEP-701, are in phase 1 and 2 clinical trials, and a series of AstraZeneca Trk ...
Subject: Cancer
Price: $3.00
*
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma
2009 NOV 16 ... Non-Hodgkin Lymphoma, Oncology, Regulatory Actions, U.S. Food and Drug Administration, Cephalon Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Non-Hodgkin Lymphoma
Price: $3.00
*
PROMACTA Awarded 2009 Prix Galien for Best Biotechnology Product
2009 OCT 19 ... pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, Pfizer and Wyeth Pharmaceuticals. With nine ... Development, Drug Discovery, Drugs, Eltrombopag, GlaxoSmithKline, Ligand Pharmaceuticals Inc., Marketing and Licensing Agreements, Pharmaceutical Business, Pharmaceutical Company, ...
Subject: Ligand Pharmaceuticals Incorporated
Price: $3.00
*
Reportlinker Adds Evolving Trends in Biopharmaceutical Licensing: Deal Assessments, Drivers and Resistors Report
2009 NOV 2 ... 76 Gilead: diversification after market domination 80 Cephalon: a Biopharma out-licensor 83 Alnylam: a developer of novel therapeutics ...
Subject: ReportLinker
Price: $3.00
*
Researchers at Cephalon, Inc. target bipolar disorder
2009 SEP 21 ... 2009;205(3):369-377). For more information, contact D.G. Flood, Cephalon Inc., Worldwide Discovery Research, CNS Biology, 145 Brandywine Pkwy, W Chester, PA 19380, ...
Subject: Bipolar Disorder
Price: $3.00
*
Study results from Nara Women's University, Department of Biological Sciences in the area of transplantation published
2009 OCT 13 ... an antero-ventral quadrant of the optic vesicle and the surrounding part of the anterior cephalon. The original dorso-ventral polarity of the transplant was once cancelled and ...
Subject: Transplantation
View Free
Daily News
Article
The Franklin Institute Announces the 2010 Franklin Institute Laureates
2009 NOV 2 ... support since 2003 as the Presenting Sponsor of the Awards Ceremony and Dinner, and Cephalon, Inc. is the Awards Week Sponsor and Associate Sponsor of the Awards Ceremony and ...
Subject: Cancer
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login